Garber Alan M
Insider CIK 1312907 · VRTX Director · EXEL Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| VRTX VERTEX PHARMACEUTICALS INC | A Award deriv | 2026-10-15 | 2026-10-19 | 29 | $512.44 | $15.0K | 95 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | A Award deriv | 2026-07-15 | 2026-07-17 | 32 | $475.28 | $15.0K | 65 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | A Award deriv | 2026-05-01 | 2026-05-05 | 1,433 | — | $0 | 1,433 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | A Award | 2026-05-01 | 2026-05-05 | 472 | — | $0 | 7,344 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | A Award deriv | 2026-04-15 | 2026-04-17 | 34 | $442.50 | $15.0K | 34 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | A Award deriv | 2025-05-01 | 2025-05-05 | 1,199 | — | $0 | 1,199 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | A Award | 2025-05-01 | 2025-05-05 | 398 | — | $0 | 6,872 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | A Award deriv | 2024-05-01 | 2024-05-03 | 3,142 | — | $0 | 3,142 | SEC↗ |
| EXEL EXELIXIS, INC. | M Exercise deriv | 2024-03-21 | 2024-03-25 | 23,491 | — | $0 | 0 | SEC↗ |
| EXEL EXELIXIS, INC. | M Exercise | 2024-03-21 | 2024-03-25 | 23,491 | $19.57 | $459.7K | 54,908 | SEC↗ |
| EXEL EXELIXIS, INC. | S Sale | 2024-03-21 | 2024-03-25 | 19,205 | $24.01 | $461.1K | 35,703 | SEC↗ |
| EXEL EXELIXIS, INC. | A Award deriv | 2023-06-01 | 2023-06-02 | 44,087 | — | $0 | 44,087 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | A Award deriv | 2023-05-01 | 2023-05-03 | 1,741 | — | $0 | 1,741 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | A Award | 2023-05-01 | 2023-05-03 | 584 | — | $0 | 6,474 | SEC↗ |
| EXEL EXELIXIS, INC. | M Exercise deriv | 2023-02-21 | 2023-02-23 | 40,000 | — | $0 | 0 | SEC↗ |
| EXEL EXELIXIS, INC. | M Exercise | 2023-02-21 | 2023-02-23 | 40,000 | $6.30 | $252.0K | 71,417 | SEC↗ |
| EXEL EXELIXIS, INC. | S Sale | 2023-02-21 | 2023-02-23 | 40,000 | $17.49 | $699.6K | 31,417 | SEC↗ |
| EXEL EXELIXIS, INC. | A Award deriv | 2022-05-26 | 2022-05-27 | 42,422 | — | $0 | 42,422 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | A Award deriv | 2022-05-01 | 2022-05-03 | 4,462 | — | $0 | 4,462 | SEC↗ |
| EXEL EXELIXIS, INC. | M Exercise deriv | 2022-03-01 | 2022-03-03 | 40,000 | — | $0 | 0 | SEC↗ |
| EXEL EXELIXIS, INC. | S Sale | 2022-03-01 | 2022-03-03 | 21,301 | $21.00 | $447.3K | 31,417 | SEC↗ |
| EXEL EXELIXIS, INC. | M Exercise | 2022-03-01 | 2022-03-03 | 40,000 | $3.13 | $125.2K | 52,718 | SEC↗ |
| EXEL EXELIXIS, INC. | A Award deriv | 2021-05-27 | 2021-05-28 | 33,549 | — | $0 | 33,549 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | A Award deriv | 2021-05-01 | 2021-05-04 | 6,067 | — | $0 | 6,067 | SEC↗ |
| EXEL EXELIXIS, INC. | M Exercise deriv | 2021-03-15 | 2021-03-17 | 40,000 | — | $0 | 0 | SEC↗ |
| EXEL EXELIXIS, INC. | M Exercise | 2021-03-15 | 2021-03-17 | 40,000 | $3.38 | $135.2K | 52,718 | SEC↗ |
| EXEL EXELIXIS, INC. | S Sale | 2021-03-15 | 2021-03-17 | 40,000 | $23.60 | $944.0K | 12,718 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | A Award deriv | 2020-06-01 | 2020-06-03 | 2,264 | — | $0 | 2,264 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | A Award | 2020-06-01 | 2020-06-03 | 699 | — | $0 | 5,890 | SEC↗ |
| EXEL EXELIXIS, INC. | S Sale | 2020-05-22 | 2020-05-22 | 36,111 | $24.42 | $881.8K | 12,718 | SEC↗ |
| EXEL EXELIXIS, INC. | A Award deriv | 2020-05-21 | 2020-05-22 | 30,750 | — | $0 | 30,750 | SEC↗ |
| EXEL EXELIXIS, INC. | S Sale | 2020-02-14 | 2020-02-14 | 12,500 | $21.02 | $262.8K | 48,829 | SEC↗ |
| EXEL EXELIXIS, INC. | M Exercise deriv | 2020-01-07 | 2020-01-09 | 56,956 | — | $0 | 0 | SEC↗ |
| EXEL EXELIXIS, INC. | M Exercise deriv | 2020-01-07 | 2020-01-09 | 30,000 | — | $0 | 0 | SEC↗ |
| EXEL EXELIXIS, INC. | M Exercise | 2020-01-07 | 2020-01-09 | 56,956 | $5.82 | $331.5K | 148,285 | SEC↗ |
| EXEL EXELIXIS, INC. | M Exercise | 2020-01-07 | 2020-01-09 | 30,000 | $4.58 | $137.4K | 91,329 | SEC↗ |
| EXEL EXELIXIS, INC. | S Sale | 2020-01-07 | 2020-01-09 | 86,956 | $18.01 | $1.57M | 61,329 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | A Award deriv | 2019-06-01 | 2019-06-04 | 3,330 | — | $0 | 3,330 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | A Award | 2019-06-01 | 2019-06-04 | 1,191 | — | $0 | 5,191 | SEC↗ |
| EXEL EXELIXIS, INC. | A Award deriv | 2019-05-23 | 2019-05-24 | 42,641 | — | $0 | 42,641 | SEC↗ |
| EXEL EXELIXIS, INC. | S Sale deriv | 2019-04-01 | 2019-04-03 | 15,000 | — | $0 | 0 | SEC↗ |
| EXEL EXELIXIS, INC. | S Sale deriv | 2019-04-01 | 2019-04-03 | 15,000 | — | $0 | 0 | SEC↗ |
| EXEL EXELIXIS, INC. | S Sale | 2019-04-01 | 2019-04-03 | 15,000 | $24.00 | $360.0K | 61,329 | SEC↗ |
| EXEL EXELIXIS, INC. | M Exercise | 2019-04-01 | 2019-04-03 | 15,000 | $5.92 | $88.8K | 76,329 | SEC↗ |
| EXEL EXELIXIS, INC. | M Exercise | 2019-04-01 | 2019-04-03 | 15,000 | $4.57 | $68.5K | 76,329 | SEC↗ |
| EXEL EXELIXIS, INC. | S Sale | 2019-04-01 | 2019-04-03 | 15,000 | $23.97 | $359.6K | 61,329 | SEC↗ |
| EXEL EXELIXIS, INC. | M Exercise deriv | 2019-01-08 | 2019-01-09 | 11,250 | — | $0 | 0 | SEC↗ |
| EXEL EXELIXIS, INC. | M Exercise | 2019-01-08 | 2019-01-09 | 11,250 | $4.16 | $46.8K | 72,579 | SEC↗ |
| EXEL EXELIXIS, INC. | S Sale | 2019-01-08 | 2019-01-09 | 11,250 | $23.00 | $258.8K | 61,329 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | A Award deriv | 2018-06-01 | 2018-06-05 | 3,229 | — | $0 | 3,229 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | A Award | 2018-06-01 | 2018-06-05 | 1,801 | — | $0 | 4,000 | SEC↗ |
| EXEL EXELIXIS, INC. | A Award deriv | 2018-05-24 | 2018-05-24 | 31,167 | — | $0 | 31,167 | SEC↗ |
| EXEL EXELIXIS, INC. | M Exercise deriv | 2018-04-16 | 2018-04-18 | 15,000 | — | $0 | 0 | SEC↗ |
| EXEL EXELIXIS, INC. | S Sale | 2018-04-16 | 2018-04-18 | 15,000 | $20.25 | $303.8K | 61,329 | SEC↗ |
| EXEL EXELIXIS, INC. | M Exercise | 2018-04-16 | 2018-04-18 | 15,000 | $11.66 | $174.9K | 76,329 | SEC↗ |
| EXEL EXELIXIS, INC. | M Exercise deriv | 2018-01-09 | 2018-01-10 | 11,500 | — | $0 | 0 | SEC↗ |
| EXEL EXELIXIS, INC. | S Sale | 2018-01-09 | 2018-01-10 | 11,500 | $30.00 | $345.0K | 61,329 | SEC↗ |
| EXEL EXELIXIS, INC. | M Exercise | 2018-01-09 | 2018-01-10 | 11,500 | $7.97 | $91.7K | 72,829 | SEC↗ |
| EXEL EXELIXIS, INC. | M Exercise deriv | 2018-01-08 | 2018-01-10 | 3,500 | — | $0 | 11,500 | SEC↗ |
| EXEL EXELIXIS, INC. | S Sale | 2018-01-08 | 2018-01-10 | 3,500 | $31.29 | $109.5K | 61,329 | SEC↗ |
| EXEL EXELIXIS, INC. | M Exercise | 2018-01-08 | 2018-01-10 | 3,500 | $7.97 | $27.9K | 64,829 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise deriv | 2017-06-08 | 2017-06-09 | 5,320 | — | $0 | 5,320 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | A Award | 2017-06-08 | 2017-06-09 | 2,199 | — | $0 | 2,199 | SEC↗ |
| EXEL EXELIXIS, INC. | A Award deriv | 2017-05-25 | 2017-05-26 | 23,491 | — | $0 | 23,491 | SEC↗ |
| EXEL EXELIXIS, INC. | M Exercise deriv | 2016-12-09 | 2016-12-09 | 10,000 | — | $0 | 0 | SEC↗ |
| EXEL EXELIXIS, INC. | M Exercise | 2016-12-09 | 2016-12-09 | 10,000 | $10.53 | $105.3K | 69,161 | SEC↗ |
| EXEL EXELIXIS, INC. | S Sale | 2016-12-09 | 2016-12-09 | 7,832 | $16.90 | $132.4K | 61,329 | SEC↗ |
| EXEL EXELIXIS, INC. | A Award deriv | 2016-05-26 | 2016-05-26 | 40,000 | — | $0 | 40,000 | SEC↗ |
| EXEL EXELIXIS, INC. | A Award | 2016-01-04 | 2016-01-05 | 10,550 | — | $0 | 59,161 | SEC↗ |
| EXEL EXELIXIS, INC. | A Award deriv | 2015-05-28 | 2015-05-28 | 40,000 | — | $0 | 40,000 | SEC↗ |
| EXEL EXELIXIS, INC. | A Award | 2014-10-14 | 2014-10-16 | 48,611 | — | $0 | 48,611 | SEC↗ |
| EXEL EXELIXIS, INC. | A Award deriv | 2014-05-29 | 2014-05-30 | 40,000 | — | $0 | 40,000 | SEC↗ |
| EXEL EXELIXIS, INC. | A Award deriv | 2013-12-06 | 2013-12-09 | 56,956 | — | $0 | 56,956 | SEC↗ |
| EXEL EXELIXIS, INC. | A Award deriv | 2013-05-23 | 2013-05-24 | 30,000 | — | $0 | 30,000 | SEC↗ |
| EXEL EXELIXIS INC | A Award deriv | 2012-05-24 | 2012-05-25 | 15,000 | — | $0 | 15,000 | SEC↗ |